Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Generating induced pluripotent stem cells for multiple sclerosis therapy.
A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing-remitting multiple sclerosis.
Patient expression of emotions and neurologist responses in first multiple sclerosis consultations.
Epidemiology of multiple sclerosis: results from a large observational study in the UK.
Pharmaceutical approval update.
Multiparity in women with multiple sclerosis causes less long-term disability: No.
Vitamin D3 influence the Th1/Th2 ratio in C57BL/6 induced model of experimental autoimmune encephalomyelitis.
Correction: Imatinib Ameliorates Neuroinflammation in a Rat Model of Multiple Sclerosis by Enhancing Blood-Brain Barrier Integrity and by Modulating the Peripheral Immune Response.
Emotional dysfunctions in neurodegenerative diseases.
IgM-monoclonal gammopathy neuropathy and tremor: A first epidemiologic case control study.
Plasma homocysteine levels in patients with multiple sclerosis in the Greek population.
The impact of diagnostic criteria for neuromyelitis optica in patients with MS: a 10-year follow-up of the South Atlantic Project.
Bridging, switching or drug holidays - how to treat a patient who stops natalizumab?
A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS.
Mechanisms of restriction of viral neuroinvasion at the blood-brain barrier.
Orthopaedic Management of Spasticity.
Olig1 Acetylation and Nuclear Export Mediate Oligodendrocyte Development.
European multiple sclerosis risk variants in the south Asian population.
The detection of THC, CBD and CBN in the oral fluid of Sativex(®) patients using two on-site screening tests and LC-MS/MS.
[Therapeutic use of cannabis derivatives].
Central nervous system involvement in primary Sjogren`s syndrome manifesting as multiple sclerosis.
Neuromyelitis optica pathology in rats following intraperitoneal injection of NMO-IgG and intracerebral needle injury.
A combined post-mortem magnetic resonance imaging and quantitative histological study of multiple sclerosis pathology.
Neuromyelitis optica-like pathology is dependent on Type I interferon response.
Targeting Potassium Channels Kv1.3 and KC a 3.1: Routes to Selective Immunomodulators in Autoimmune Disorder Treatment?
Pages
« first
‹ previous
…
502
503
504
505
506
507
508
509
510
…
next ›
last »